Find clinical trials for Asthma in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Asthma trials near New York, NY, USA:
This is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerba....
Phase 2
New York, New York, United States and 6 other locations
in patients ≥ 6 to < 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations a...
Phase 3
Bronx, New York, United States and 80 other locations
28-week Phase 3 Efficacy and Safety Study of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma...
Phase 3
Woodhaven, New York, United States and 121 other locations
This is a study designed to evaluate efficacy and safety of Tezepelumab in reducing oral corticosteroid use in adult patients with severe asthma...
Phase 3
Bronx, New York, United States and 76 other locations
The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...
Phase 2
Bronx, New York, United States and 43 other locations
is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...
Phase 3
Edison, New Jersey, United States and 45 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Edison, New Jersey, United States and 117 other locations
Primary Objective:To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a pre...
Phase 3
New York, New York, United States and 79 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Staten Island, New York, United States and 97 other locations
to therapy acting directly on the anti-IL-4R. This will be conducted by examining the effect of a 48 week therapy with dupilumab on the rate of asthma...
Phase 4
Bronx, New York, United States and 6 other locations
Clinical trials
Research sites
Resources
Legal